<DOC>
	<DOC>NCT00390975</DOC>
	<brief_summary>This study will assess gastric emptying in patients with symptoms of diabetic gastroparesis treated with tegaserod over 2 weeks.</brief_summary>
	<brief_title>Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>Females and males 18 to 75 years of age History of type I or type II diabetes mellitus for more than 3 years History of upper gastrointestinal symptoms consistent with diabetic gastroparesis Hemoglobin A1c &lt; 9.5% Delayed gastric emptying Abnormal endoscopy finding that can explain the presence of gastroparesis symptoms Medical conditions affecting gastric emptying A clinically significant medical condition that would interfere with the patient completing the trial Clinically significant abnormal creatinine level Known allergies to the same class of drug and/or allergies to eggs Severe obesity Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Tegaserod</keyword>
	<keyword>diabetes</keyword>
	<keyword>diabetic gastroparesis</keyword>
	<keyword>gastric emptying</keyword>
	<keyword>gastric retention</keyword>
	<keyword>electrogastrography</keyword>
</DOC>